These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29530340)

  • 1. Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial.
    Yang CC; Wong TW; Lee CH; Hong CH; Chang CH; Lai FJ; Lin SH; Chi CC; Lin TK; Yen H; Wu CH; Sheu HM; Lan CE
    J Dermatol Sci; 2018 Jun; 90(3):295-302. PubMed ID: 29530340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Solanum undatum extract (SR-T100) on photocarcinogenesis and photoaging of actinic keratosis.
    Yang CC; Wu CH; Wong TW; Lai FJ; Wei KC; Lin TK; Lin CS; Zhao J; Xiang L; Kao CH; Wang YJ; Lan CE; Sheu HM
    J Dermatol; 2021 Mar; 48(3):344-352. PubMed ID: 33458860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.
    Weiss J; Ulrich M; Bukhalo M; Østerdal ML; Bang B; Hanke CW
    Br J Dermatol; 2017 Jun; 176(6):1456-1464. PubMed ID: 28078678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
    Swanson N; Smith CC; Kaur M; Goldenberg G
    J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Swanson N; Smith CC; Kaur M; Goldenberg G
    J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solanum incanum extract (SR-T100) induces human cutaneous squamous cell carcinoma apoptosis through modulating tumor necrosis factor receptor signaling pathway.
    Wu CH; Liang CH; Shiu LY; Chang LC; Lin TS; Lan CC; Tsai JC; Wong TW; Wei KJ; Lin TK; Chang NS; Sheu HM
    J Dermatol Sci; 2011 Aug; 63(2):83-92. PubMed ID: 21612892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.
    Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Goncalves J; Larsson T; Skov T; Swanson N
    J Drugs Dermatol; 2014 Feb; 13(2):154-60. PubMed ID: 24509965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
    Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
    J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
    Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
    Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm
    Hanke CW; Albrecht L; Skov T; Larsson T; Østerdal ML; Spelman L
    J Am Acad Dermatol; 2020 Mar; 82(3):642-650. PubMed ID: 31374304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial.
    Ulrich M; Reinhold U; Falqués M; Rodriguez Azeredo R; Stockfleth E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):390-396. PubMed ID: 28960520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.
    Korman N; Moy R; Ling M; Matheson R; Smith S; McKane S; Lee JH
    Arch Dermatol; 2005 Apr; 141(4):467-73. PubMed ID: 15837864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial.
    Erlendsson AM; Karmisholt KE; Haak CS; Stender IM; Haedersdal M
    J Am Acad Dermatol; 2016 Apr; 74(4):709-15. PubMed ID: 26810403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
    Gebauer K; Shumack S; Cowen PS
    Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.